Citadel Advisors
GNLX icon

Citadel Advisors’s Genelux GNLX Stock Holding History

Citadel Advisors’s Portfolio GNLX Stock Details GNLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20,300
Closed -$85.3K – 13176
2025
Q3 		$85.3K Buy
+20,300
New +$72.1K ﹤0.01% 11940
2025
Q2 		– Sell
-10,100
Closed -$27.3K – 13464
2025
Q1 		$27.3K Buy
+10,100
New +$37.9K ﹤0.01% 12903

Other funds holding GNLX

WDC
Woodward Diversified Capital Bakersfield, California $227M AUM 40.62% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $6.54B AUM

Citadel Advisors's GNLX Position: Q2 2026 in Review

Citadel Advisors opened a new position in Genelux (GNLX) in Q2 2026: 85,481 shares worth $257K. The stake represents ﹤0.01% of the portfolio and ranks #11471 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in GNLX as recently as Q4 2025.

Citadel Advisors first reported a position in GNLX in Q1 2023 and has held it in 9 quarters since. The position peaked at $294K in Q1 2023. 72 funds tracked by Wall St. Rank hold GNLX as of Q2 2026.

  • Citadel Advisors held 85,481 shares of Genelux worth $257K as of Q2 2026.
  • Genelux was a new Citadel Advisors position in Q2 2026.
  • Genelux made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #11471 holding.
  • Citadel Advisors first reported a position in Genelux in Q1 2023 and has held it in 9 quarters since.
  • Citadel Advisors's Genelux position peaked at $294K in Q1 2023.
  • 72 funds tracked by Wall St. Rank held Genelux as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.